26
Participants
Start Date
January 31, 2013
Primary Completion Date
September 30, 2013
Study Completion Date
September 30, 2013
glucose clamp
Each subject will complete one adaptation night visit followed by two experimental night visits, one normoglycaemic and one hypoglycaemic, in randomised order. While subjects are asleep, sleep patterns will be monitored online using polysomnographic recordings during a hypoglycaemic and a normoglycaemic clamp (using constant intravenous (i.v.) infusion of human soluble insulin (Actrapid®)). Plasma glucose will be monitored.
Novo Nordisk Investigational Site, Glostrup Municipality
Lead Sponsor
Novo Nordisk A/S
INDUSTRY